Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000351636

Medchemexpress LLC HPK1-IN-7 | 2320462-65-3 | 99.3% | 458.47 | 50 MG
SDP

Catalog No. 5000351636
Encompass_Preferred

HPK1-IN-7 is a potent, orally active HPK1 (hematopoietic progenitor kinase 1, MAP4K1) inhibitor (IC50 = 2.6 nM) with excellent family and kinome selectivity. It shows selectivity against IRAK4 (59 nM) and GLK (140 nM). HPK1-IN-7 shows robust efficacy against MC38 syngeneic tumor model in combination with anti-PD1.

  • Potent, orally active HPK1 inhibitor (IC50 = 2.6 nM)
  • Excellent family and kinome selectivity
  • Shows selectivity against IRAK4 (59 nM) and GLK (140 nM)
  • Robust efficacy against MC38 syngeneic tumor model in combination with anti-PD1

Catalog No. 50-003-51636 Supplier Medchemexpress LLC Supplier No. HY13874250MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

HPK1-IN-7 is a potent, orally active HPK1 (hematopoietic progenitor kinase 1, MAP4K1) inhibitor (IC50 = 2.6 nM) with excellent family and kinome selectivity. It shows selectivity against IRAK4 (59 nM) and GLK (140 nM). HPK1-IN-7 shows robust efficacy against MC38 syngeneic tumor model in combination with anti-PD1.

  • Potent, orally active HPK1 inhibitor (IC50 = 2.6 nM)
  • Excellent family and kinome selectivity
  • Shows selectivity against IRAK4 (59 nM) and GLK (140 nM)
  • Robust efficacy against MC38 syngeneic tumor model in combination with anti-PD1

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.